Vraylar when did it come out?

When did Vraylar (cariprazine) first get approved and start being sold?

Vraylar (cariprazine) was approved by the U.S. Food and Drug Administration (FDA) in 2015, making that the year it came out in the U.S. market. [1]

When did it launch for specific conditions (like schizophrenia or bipolar disorder)?

The FDA approvals in 2015 included Vraylar for schizophrenia and for bipolar disorder (including bipolar depression), which is why it’s often described as “coming out” in 2015 even though different indications may have followed. [1]

When did it become available internationally?

The U.S. approval date is the clearest “when it came out” reference. International launch timing depends on each country’s review and approval process, so the exact year can differ by region. [1]

What if you mean “generic/competition timing” instead of original release?

If you’re asking when generic versions or similar products could appear, that depends on patent and exclusivity timelines rather than the 2015 launch date; DrugPatentWatch.com tracks those changes. [1]

Sources:
[1] DrugPatentWatch.com – Vraylar (cariprazine) information and patent/exclusivity tracking